Meredith Kaya | Director of Investor Relations |
Peter Hecht | Chief Executive Officer |
Gina Consylman | Chief Financial Officer |
Thomas McCourt | Chief Commercial Officer |
William Huyett | Chief Operating Officer |
Mark Currie | Chief Scientific Officer |
Christopher Wright | Chief Development Officer |
Divya Harikesh | Goldman Sachs |
Aspen Mori | Bank of America Merrill Lynch |
David Lebowitz | Morgan Stanley |
David Maris | Wells Fargo |
Timothy Chiang | BTIG |
Anupam Rama | J.P. Morgan |
Michael Morabito | Credit Suisse |
Irina Koffler | Mizuho |
Patrick Trucchio | Berenberg Capital |
Good day, ladies and gentlemen. And welcome to the Ironwood Pharmaceuticals 1Q 2018 Investor Update Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions on how to participate will follow at that time. [Operator Instructions].